McKesson's growth continues in FY04's second quarter

TriMed Staff | | Health Imaging | Diagnostic Imaging
McKesson Corp. reported healthy gains in revenues and earnings in its second fiscal quarter, ending Sept. 30.

 Revenues increased 23 percent to $16.8 billion, compared with $13.7 billion in the second quarter of FY03. Net income rose 25 percent to $156.5 million, compared with $124.8 million in the year-ago quarter.

 Sales in McKesson's pharmaceutical unit increased 15 percent, while its information unit contributed an 8 percent gain in revenues. McKesson expects revenue growth in its information unit to grow approximately 10 percent for the rest of FY04.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.